GVR Report cover Micro-pumps Market Size, Share & Trends Report

Micro-pumps Market Size, Share & Trends Analysis Report By Product (Mechanical, Non-mechanical), By Application (Drug Delivery, Medical Devices), By End Use, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-949-9
  • Number of Report Pages: 111
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2020
  • Forecast Period: 2021 - 2030 
  • Industry: Healthcare

Report Overview

The global micro-pumps market size is valued at USD 1.6 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 17.4% from 2022 to 2030. The rising number of pharmaceutical industries, increasing research and development in life sciences, the development and adoption of clinical tests, and high use of the micro-pump in infusion therapy are key drivers responsible for the lucrative market growth. Micro-Pumps have evolved over a short duration of time with the help of research of various techniques, availability of raw materials required for production, and advancement in digital and electronic capabilities. In addition to this, there has been an increase in the number of innovations in this product category which is fueling the growth of products in this category.

U.S. micro-pumps market size, by product, 2020 - 2030 (USD Million)

The onset of COVID-19 impacted the market in the second and third quarters of 2020 due to supply chain, operations, and distribution constraints. However, the increasing use of micro-pumps in biomedical research during the pandemic assisted in the market recovery. The micro-pumps are also used in minimally invasive surgical procedures. The rising prevalence of chronic diseases like diabetes, cancer, Ischemic Heart Diseases (IHD), and the increasing geriatric population are expected to help in the expansion of the market. According to the Centers for Disease Control and Prevention, about 659,000 people in the US die from heart disease each year, i.e., one in every four deaths. One of the major applications of drug delivery via infusion pumps is the delivery of insulin and management of the blood glucose level. In a 2021 research published by MDPI, piezoelectric micro diaphragm pump has proven effective and well adapted for drug delivery applications.

The U.S. Mechanical Micro-pumps Product Segment is expected to grow at a CAGR of 18.1% during the forecast period. Based on the region, North America dominated the market with a share of 49.4% in the year 2021. This can be attributed to high purchasing power, strong government support for quality healthcare, the presence of high-quality infrastructure for clinical and laboratory research, and the high adoption of technologically advanced products. In 2017, TTP Ventus launched its Disc Pump, a new ‘silent’ micro-pump platform based on ultrasonic resonance. The company reported that the launch of these micro-pumps could be especially useful in point-of-care diagnostic devices, causing less discomfort for patients and less inconvenience for healthcare professionals. The Disc Pump cycles at a rate of 20,000 times per second, which is one or two orders of magnitude quicker than conventional pumps,

The demand for micro-pumps escalated due to the onset of COVID-19 in 2020 as the Pumps were used in emergency care devices like ventilators, nebulizers, etc. There was a rapid increase in the number of patients admitted to the hospitals due to critical health conditions, especially during the second wave of the COVID-19 pandemic. In March 2020, The Lee Company partnered with GM and Ventec life systems to mass-produce, critically needed ventilators to fight the COVID-19 pandemic. The companies together delivered 30,000 V+ Pro ventilators in just 154 days. The increasing number of patients required more tests and other emergency care services. Hence, the increased demand for such devices and test kits during the COVID-19 pandemic indirectly led to the growth of the market.

Product Insights

The mechanical micro-pumps segment led the market and accounted for a revenue share of around 56.0% in 2021. The market is anticipated to witness growth over the forecast period. This can be attributed to the use of mechanical micro-pumps in the Micro-Electro-Mechanical Systems (MEMS). The MEMS is used in drug delivery system vehicles, these systems are very cheap, easy to be operated, capable of monitoring diseases, and providing rapid detection and delivering medicines.

Mechanical micro-Pumps consist of moving parts like micro-valve membranes or flaps and actuation. Non-mechanical micro-Pumps do not need physical actuation, like capillary micro-Pumps. Non-mechanical micro-Pumps have certain limitations such as the actuation mechanisms interfering with the pumping liquids and the use of only low conductivity fluids. The increasing biomedical application of mechanical micro Pumps such as ‘Lab On Chip’ (LOC), micro-total analysis systems, and POCT are expected to drive the growth of the market. Advanced biological sample processing, manipulation, and analysis are possible in miniature fluidic devices by using lab-on-chip (LoC) technology.

Application Insights

Drug Delivery is identified as the largest segment in 2021, accounting for around 32.5% of the market share. This can be attributed to the increasing use of micro-pumps in implanted drug delivery systems. The in-vitro diagnostic segment is expected to increase rapidly as micro-Pumps are used for early disease detection, easier monitoring, and increased personalization in the case of in-vitro diagnostics. There are also various developments in wearable medical devices that use micro-Pumps for transporting micro-fluids. For instance, in March 2022, Medtronic launched its MiniMed 780 G systems in India. The system is a part of the new Medtronic portfolio of insulin pumps with smartphone technology via Bluetooth connectivity.

Global micro-pumps market share, by application, 2021 (%)

Such research on new techniques of drug delivery seeks to develop micro devices capable of delivering exact quantities of close to the treatment site as possible and at right time. These devices are incorporated with micro-pumps, silicon micro-machined needles, or controlled-release propellants for drug delivery, storage, and dispensing. The rising awareness of controlled drug delivery system devices and increasing production of drug delivery devices is expected to demand more micro-pumps and thereby drive the market growth.

End-use Insights

The biotechnological and pharmaceutical companies segment held the largest revenue share of 39.3% in 2021. These companies require micro-Pumps for infusion therapies, biomedical research, and research therapies including vaccines. According to the April 2021 report of the Congressional Budget Office, in 2019, the pharmaceutical industry spent USD 83 billion on R & D. Also, the number of new drug approval increased by 60% compared between the years 2010 to 2019. Hence, an increase in research and development has led to increased demand for micro-Pumps and thereby contributed to the market share of biotechnological and pharmaceutical companies. Hospitals and diagnostic centers are expected to surge the market growth over the forecast period as there is an increase in the use of micro-Pumps in point-of-care diagnosis and devices used for blood transport and glucose monitoring devices used in diabetes patients.

An increase in Point-of-Care-Testing (POCT) has risen since the COVID-19 pandemic. An increase in funding and strategic initiatives by multiple sources, including the U.S. Department of Defense (DOD), the NIH, and NBIB has been taken. For instance, in October 2020, the National Institute of Biomedical Imaging and Bioengineering created the Point-of-Care-Technologies Research Network to drive the development of point-of-care diagnostic technologies. POCT has the potential for early disease diagnosis, treatment of noncommunicable diseases, easier monitoring, and increased personalization. Rapid, reliable, and low-cost diagnostic tools at point-of-care (PoC) are therefore in high demand.

Regional Insights

North America dominated the micro-pumps market and held the largest revenue share of 49.4% in 2021. High purchasing power, strong government support for quality healthcare, the presence of high-quality infrastructure for clinical and laboratory research, and high adoption of technologically advanced products are a few of the reasons driving regional market progress. Furthermore, the rise of the regional market has been aided by increased government support for medical devices and their approvals in this region. Likewise, advantageous government initiatives to assist research and development in the relevant industry are increasing the usage of devices made with micro-pumps, enhancing the market's growth.

Asia Pacific is projected to be the fastest-growing market over the forecast period owing to its increasing quality healthcare infrastructure, competent workforce, increasing awareness of healthcare products, rise in point-of-care diagnostic centers, and rigorous research and development initiatives. In 2017-18, India spent 0.7 percent of its GDP on research and development, compared to 2.1 percent in China, 0.8 percent in South Africa, 1.3 percent in Brazil, and 1.1 percent in Russia.

Key Companies & Market Share Insights

New product developments, collaborations, regional expansion, and mergers are key strategic initiatives undertaken. For instance, In January 2022, Bartels Mikrotechnik GmbH, Inc. introduced the mp6 series of micro-pumps. The mp6 series consists of mp6-Liq, mp6-gas, and mp6-gas+. Other key layers are focused on partnerships and mergers that will allow them to introduce new products in different markets. In September 2018, Sensile Medical AG (A Subsidiary of Gerresheimer) received EU certification for the European market. A European Company obtained a CE declaration of conformity for the micro-rotatory pump used in the treatment of advanced Parkinson’s disease. Some of the prominent players in the micro-pumps market include:

  • Bartels Mikrotechnik GmbH

  • Bürkert Fluid Control Systems


  • The Lee Company

  • Xiamen AJK Technology Co., Ltd.

  • Xavitech

  • ALLDOO Micropump

  • Servoflo Corporation

  • Dolomite Microfluidics (Backtrace Holdings Ltd.)

  • TTp ventus

  • Arcmed Group (Halma)

Micro-pumps Market Report Scope

Report Attribute


Market size value in 2022

USD 1.88 billion

Revenue forecast in 2030

USD 6.79 billion

Growth Rate

CAGR of 17.4% from 2022 to 2030

Base year for estimation


Historical data

2018 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million and CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Products, applications, end-use

Regional Scope

North America; Europe; Asia Pacific; Latin America; MEA

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; India; China; Japan; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

Bartels Mikrotechnik GmbH; Bürkert Fluid Control Systems; TOPS INDUSTRY & TECHNOLOGY CO., LTD.; The Lee Company; Xiamen AJK Technology Co., Ltd.; Xavitech; ALLDOO Micropump; Servoflo Corporation; Dolomite Microfluidics(Backtrace Holdings Ltd.); TTp ventus; Arcmed Group (Halma)

Customization scope

Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail of customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global micro-pumps market report based on products, applications, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Mechanical

    • Non-mechanical

  • Application Outlook (Revenue, USD Million, 2018 - 2030)

    • Drug Delivery

    • In-vitro Diagnostics

    • Medical Devices

    • Others

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)

    • Biotechnological & Pharmaceutical Companies

    • Hospitals & Diagnostic Centers

    • Academic & Research Institutes

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Italy

      • U.K.

      • Germany

      • France

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.